

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 6.28666231 |
| 2 | regulation of relaxation of muscle (GO:1901077) | 6.24806949 |
| 3 | striated muscle contraction (GO:0006941) | 5.99289558 |
| 4 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.89261799 |
| 5 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.83500226 |
| 6 | cardiac muscle contraction (GO:0060048) | 5.73196124 |
| 7 | actin filament-based movement (GO:0030048) | 5.43095560 |
| 8 | regulation of actin filament-based movement (GO:1903115) | 5.26066857 |
| 9 | regulation of cell communication by electrical coupling (GO:0010649) | 5.20315988 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.01542293 |
| 11 | creatine metabolic process (GO:0006600) | 4.94565171 |
| 12 | actomyosin structure organization (GO:0031032) | 4.89020916 |
| 13 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.87867527 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 4.86121050 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.86121050 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 4.85579627 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.85579627 |
| 18 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.80759805 |
| 19 | cardiac muscle hypertrophy (GO:0003300) | 4.70294154 |
| 20 | response to inactivity (GO:0014854) | 4.67021083 |
| 21 | lysine catabolic process (GO:0006554) | 4.56817518 |
| 22 | lysine metabolic process (GO:0006553) | 4.56817518 |
| 23 | carnitine shuttle (GO:0006853) | 4.55433282 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 4.52901306 |
| 25 | response to muscle activity (GO:0014850) | 4.52390990 |
| 26 | muscle contraction (GO:0006936) | 4.49371689 |
| 27 | actin-myosin filament sliding (GO:0033275) | 4.47472787 |
| 28 | muscle filament sliding (GO:0030049) | 4.47472787 |
| 29 | NADH metabolic process (GO:0006734) | 4.46699370 |
| 30 | striated muscle hypertrophy (GO:0014897) | 4.45369026 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.45169379 |
| 32 | regulation of the force of heart contraction (GO:0002026) | 4.38485127 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.28446123 |
| 34 | 2-oxoglutarate metabolic process (GO:0006103) | 4.23988963 |
| 35 | sarcomere organization (GO:0045214) | 4.22457680 |
| 36 | kynurenine metabolic process (GO:0070189) | 4.20985336 |
| 37 | glyoxylate metabolic process (GO:0046487) | 4.15959316 |
| 38 | aromatic amino acid family catabolic process (GO:0009074) | 4.15589976 |
| 39 | plasma membrane repair (GO:0001778) | 4.13568366 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.10974639 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 4.08118729 |
| 42 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.07492415 |
| 43 | regulation of skeletal muscle contraction (GO:0014819) | 4.06814158 |
| 44 | muscle system process (GO:0003012) | 4.04232336 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.98898587 |
| 46 | fatty acid beta-oxidation (GO:0006635) | 3.98237875 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.96685477 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.95138561 |
| 49 | regulation of protein activation cascade (GO:2000257) | 3.94557363 |
| 50 | skeletal muscle fiber development (GO:0048741) | 3.93984728 |
| 51 | muscle hypertrophy (GO:0014896) | 3.92734985 |
| 52 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.90924642 |
| 53 | regulation of striated muscle contraction (GO:0006942) | 3.89821970 |
| 54 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.88454743 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83626597 |
| 56 | sulfur amino acid catabolic process (GO:0000098) | 3.82759321 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.82374094 |
| 58 | muscle tissue morphogenesis (GO:0060415) | 3.82157226 |
| 59 | aspartate family amino acid catabolic process (GO:0009068) | 3.81444711 |
| 60 | bile acid biosynthetic process (GO:0006699) | 3.77220308 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 3.76453748 |
| 62 | complement activation, alternative pathway (GO:0006957) | 3.76452230 |
| 63 | actin-mediated cell contraction (GO:0070252) | 3.75693023 |
| 64 | cell communication involved in cardiac conduction (GO:0086065) | 3.75200379 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.75189907 |
| 66 | regulation of complement activation (GO:0030449) | 3.74547774 |
| 67 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.71660045 |
| 68 | skeletal muscle adaptation (GO:0043501) | 3.71207415 |
| 69 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.70289278 |
| 70 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.69224742 |
| 71 | protein carboxylation (GO:0018214) | 3.69224742 |
| 72 | regulation of fibrinolysis (GO:0051917) | 3.69002137 |
| 73 | cardiac muscle cell development (GO:0055013) | 3.68963228 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 3.68523342 |
| 75 | fatty acid oxidation (GO:0019395) | 3.66865579 |
| 76 | striated muscle adaptation (GO:0014888) | 3.65909669 |
| 77 | tricarboxylic acid cycle (GO:0006099) | 3.64238696 |
| 78 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.63520370 |
| 79 | cell communication by electrical coupling (GO:0010644) | 3.62650623 |
| 80 | tryptophan catabolic process (GO:0006569) | 3.61509492 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 3.61509492 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 3.61509492 |
| 83 | lipid oxidation (GO:0034440) | 3.60581411 |
| 84 | fatty acid catabolic process (GO:0009062) | 3.59828087 |
| 85 | myotube cell development (GO:0014904) | 3.57422733 |
| 86 | adult heart development (GO:0007512) | 3.56441832 |
| 87 | regulation of sequestering of triglyceride (GO:0010889) | 3.56423935 |
| 88 | muscle hypertrophy in response to stress (GO:0003299) | 3.55447285 |
| 89 | cardiac muscle adaptation (GO:0014887) | 3.55447285 |
| 90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.55447285 |
| 91 | positive regulation of fatty acid oxidation (GO:0046321) | 3.54004446 |
| 92 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.52416457 |
| 93 | cysteine metabolic process (GO:0006534) | 3.51972693 |
| 94 | carnitine metabolic process (GO:0009437) | 3.48871121 |
| 95 | carnitine transmembrane transport (GO:1902603) | 3.48829226 |
| 96 | urea metabolic process (GO:0019627) | 3.45748040 |
| 97 | urea cycle (GO:0000050) | 3.45748040 |
| 98 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44641995 |
| 99 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44641995 |
| 100 | regulation of fatty acid oxidation (GO:0046320) | 3.44497338 |
| 101 | ethanol oxidation (GO:0006069) | 3.44283400 |
| 102 | cardiac cell development (GO:0055006) | 3.43369982 |
| 103 | serine family amino acid catabolic process (GO:0009071) | 3.41350785 |
| 104 | tryptophan metabolic process (GO:0006568) | 3.40272627 |
| 105 | monocarboxylic acid catabolic process (GO:0072329) | 3.39801893 |
| 106 | short-chain fatty acid metabolic process (GO:0046459) | 3.36840638 |
| 107 | triglyceride homeostasis (GO:0070328) | 3.36270378 |
| 108 | acylglycerol homeostasis (GO:0055090) | 3.36270378 |
| 109 | muscle cell cellular homeostasis (GO:0046716) | 3.36215013 |
| 110 | coenzyme catabolic process (GO:0009109) | 3.32990001 |
| 111 | homocysteine metabolic process (GO:0050667) | 3.32900938 |
| 112 | alpha-amino acid catabolic process (GO:1901606) | 3.32855004 |
| 113 | valine metabolic process (GO:0006573) | 3.31880955 |
| 114 | plasma lipoprotein particle clearance (GO:0034381) | 3.31548200 |
| 115 | muscle fiber development (GO:0048747) | 3.30924253 |
| 116 | positive regulation of lipid catabolic process (GO:0050996) | 3.30651046 |
| 117 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.30604441 |
| 118 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.29634977 |
| 119 | glycogen catabolic process (GO:0005980) | 3.29057983 |
| 120 | cardiac myofibril assembly (GO:0055003) | 3.28505276 |
| 121 | phospholipid efflux (GO:0033700) | 3.27440882 |
| 122 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.27317976 |
| 123 | amino-acid betaine transport (GO:0015838) | 3.27301026 |
| 124 | carnitine transport (GO:0015879) | 3.27301026 |
| 125 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.26880299 |
| 126 | glycogen biosynthetic process (GO:0005978) | 3.26201876 |
| 127 | glucan biosynthetic process (GO:0009250) | 3.26201876 |
| 128 | myofibril assembly (GO:0030239) | 3.24874834 |
| 129 | branched-chain amino acid catabolic process (GO:0009083) | 3.23036228 |
| 130 | regulation of cholesterol esterification (GO:0010872) | 3.22999445 |
| 131 | nitrogen cycle metabolic process (GO:0071941) | 3.21841873 |
| 132 | sodium ion export (GO:0071436) | 3.20781108 |
| 133 | ketone body metabolic process (GO:1902224) | 3.20509884 |
| 134 | negative regulation of protein activation cascade (GO:2000258) | 3.20090857 |
| 135 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.19631447 |
| 136 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19012554 |
| 137 | phospholipid homeostasis (GO:0055091) | 3.17712782 |
| 138 | reverse cholesterol transport (GO:0043691) | 3.17636174 |
| 139 | protein-lipid complex remodeling (GO:0034368) | 3.16804143 |
| 140 | macromolecular complex remodeling (GO:0034367) | 3.16804143 |
| 141 | plasma lipoprotein particle remodeling (GO:0034369) | 3.16804143 |
| 142 | regulation of membrane repolarization (GO:0060306) | 3.16663649 |
| 143 | relaxation of muscle (GO:0090075) | 3.16191082 |
| 144 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.15947556 |
| 145 | skeletal muscle tissue development (GO:0007519) | 3.15693335 |
| 146 | relaxation of cardiac muscle (GO:0055119) | 3.15642986 |
| 147 | cellular amino acid catabolic process (GO:0009063) | 3.14434813 |
| 148 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.14300197 |
| 149 | bile acid metabolic process (GO:0008206) | 3.11251401 |
| 150 | fibrinolysis (GO:0042730) | 3.07343727 |
| 151 | carboxylic acid catabolic process (GO:0046395) | 3.06036659 |
| 152 | organic acid catabolic process (GO:0016054) | 3.06036659 |
| 153 | cellular modified amino acid catabolic process (GO:0042219) | 3.05599916 |
| 154 | oxaloacetate metabolic process (GO:0006107) | 3.05220027 |
| 155 | response to epinephrine (GO:0071871) | 3.04069081 |
| 156 | aromatic amino acid family metabolic process (GO:0009072) | 3.03931514 |
| 157 | glucan catabolic process (GO:0009251) | 3.02882045 |
| 158 | striated muscle atrophy (GO:0014891) | 3.00731254 |
| 159 | cellular glucuronidation (GO:0052695) | 3.00299282 |
| 160 | heart process (GO:0003015) | 3.00214904 |
| 161 | heart contraction (GO:0060047) | 3.00214904 |
| 162 | fatty acid homeostasis (GO:0055089) | 3.00092190 |
| 163 | tyrosine metabolic process (GO:0006570) | 2.99906758 |
| 164 | striated muscle cell development (GO:0055002) | 2.99592398 |
| 165 | regulation of heart rate (GO:0002027) | 2.97617478 |
| 166 | muscle adaptation (GO:0043500) | 2.97588930 |
| 167 | cellular response to epinephrine stimulus (GO:0071872) | 2.93900322 |
| 168 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.93611272 |
| 169 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.93611272 |
| 170 | regulation of heart contraction (GO:0008016) | 2.92751922 |
| 171 | regulation of muscle system process (GO:0090257) | 2.91720111 |
| 172 | negative regulation of protein localization to cell surface (GO:2000009) | 2.89874370 |
| 173 | gluconeogenesis (GO:0006094) | 2.84113036 |
| 174 | regulation of muscle contraction (GO:0006937) | 2.83527778 |
| 175 | regulation of cardiac muscle contraction (GO:0055117) | 2.82867695 |
| 176 | regulation of ATP catabolic process (GO:1903289) | 2.81199563 |
| 177 | regulation of ATPase activity (GO:0043462) | 2.81199563 |
| 178 | cellular polysaccharide catabolic process (GO:0044247) | 2.80592830 |
| 179 | muscle structure development (GO:0061061) | 2.79580495 |
| 180 | cardiac muscle cell action potential (GO:0086001) | 2.79523098 |
| 181 | muscle organ development (GO:0007517) | 2.79372216 |
| 182 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.78089555 |
| 183 | detection of calcium ion (GO:0005513) | 2.77078316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.39971223 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.45327637 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76120287 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.15558201 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60921532 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.86354925 |
| 7 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.63241781 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41749930 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.35282718 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.04401661 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.00201618 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.82852927 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47959304 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.41875200 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.34495431 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.14453852 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09123002 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.96301343 |
| 19 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94959961 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94258251 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.83385624 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83375158 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82477245 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.76980704 |
| 25 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.76980704 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72625704 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.72095161 |
| 28 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69632589 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.61411150 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59975695 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.58470719 |
| 32 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.58470719 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56729047 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53742663 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51198544 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51062761 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.49956863 |
| 38 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45794114 |
| 39 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43995575 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43370372 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.42032326 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40150241 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39829817 |
| 44 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39722663 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35680663 |
| 46 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35456653 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34721229 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.34360419 |
| 49 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33828037 |
| 50 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33510571 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30708305 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30405496 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28740057 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25611636 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21802873 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20704263 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19590249 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18954222 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18549474 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17813800 |
| 61 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.17483187 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13878207 |
| 63 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12460453 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09164714 |
| 65 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08548819 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08091926 |
| 67 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06864825 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06756785 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05574610 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05197075 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05164062 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04918742 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03867703 |
| 74 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03449433 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03382307 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03382307 |
| 77 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03244613 |
| 78 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03074761 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02396665 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02190202 |
| 81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01453230 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00936115 |
| 83 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00537883 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98969981 |
| 85 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98449259 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98445736 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98253725 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97618452 |
| 89 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97268725 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96241020 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96129090 |
| 92 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95714126 |
| 93 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93854411 |
| 94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93608272 |
| 95 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.93013530 |
| 96 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91951936 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91825270 |
| 98 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91284025 |
| 99 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.90440234 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89882127 |
| 101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89576640 |
| 102 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89443111 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88362502 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88305362 |
| 105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88221929 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85984559 |
| 107 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85522196 |
| 108 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.83628475 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83587365 |
| 110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82687308 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82010012 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81325354 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80749950 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80742718 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79922077 |
| 116 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79858419 |
| 117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79406944 |
| 118 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78695596 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77360133 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.76574046 |
| 121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75012926 |
| 122 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74368689 |
| 123 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.74009155 |
| 124 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.73601036 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72712469 |
| 126 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.72071693 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71857321 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.71004195 |
| 129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70928600 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69199423 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.68441573 |
| 132 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.67640616 |
| 133 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66567922 |
| 134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.66529252 |
| 135 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.65564452 |
| 136 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64356725 |
| 137 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.64007317 |
| 138 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.64007317 |
| 139 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.63440250 |
| 140 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62716742 |
| 141 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62353980 |
| 142 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.62226786 |
| 143 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.62075170 |
| 144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61803721 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61798103 |
| 146 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.61437245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.63591780 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.41420050 |
| 3 | MP0005360_urolithiasis | 4.09501713 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.97078386 |
| 5 | MP0005365_abnormal_bile_salt | 3.56956442 |
| 6 | MP0000751_myopathy | 3.30983810 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.26193930 |
| 8 | MP0003646_muscle_fatigue | 3.24003861 |
| 9 | MP0000749_muscle_degeneration | 3.09979651 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.85275679 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.84317730 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.58998473 |
| 13 | MP0005330_cardiomyopathy | 2.43267902 |
| 14 | MP0004130_abnormal_muscle_cell | 2.42404319 |
| 15 | MP0005083_abnormal_biliary_tract | 2.33377526 |
| 16 | MP0003252_abnormal_bile_duct | 2.26801818 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.25926348 |
| 18 | MP0004510_myositis | 2.23932987 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.21673380 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.21661971 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.21448498 |
| 22 | MP0009840_abnormal_foam_cell | 2.14427017 |
| 23 | MP0000750_abnormal_muscle_regeneration | 2.05878971 |
| 24 | MP0002269_muscular_atrophy | 1.99973060 |
| 25 | MP0000747_muscle_weakness | 1.93912419 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.90366718 |
| 27 | MP0005275_abnormal_skin_tensile | 1.87941917 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.86144988 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.83917756 |
| 30 | MP0004270_analgesia | 1.81237948 |
| 31 | MP0005332_abnormal_amino_acid | 1.79477084 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.75888437 |
| 33 | MP0003195_calcinosis | 1.75472485 |
| 34 | MP0005670_abnormal_white_adipose | 1.70271436 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.70243455 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.67160164 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.65113406 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.59690891 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.58510125 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.53398322 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.52055209 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.47602708 |
| 43 | MP0005369_muscle_phenotype | 1.46753431 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.44230922 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.44230922 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.42210244 |
| 47 | MP0001666_abnormal_nutrient_absorption | 1.40483208 |
| 48 | MP0002796_impaired_skin_barrier | 1.38260118 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.37532530 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.33768372 |
| 51 | MP0000609_abnormal_liver_physiology | 1.33390508 |
| 52 | MP0006138_congestive_heart_failure | 1.32165688 |
| 53 | MP0003137_abnormal_impulse_conducting | 1.25478333 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.25072515 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.22049785 |
| 56 | MP0002971_abnormal_brown_adipose | 1.19535856 |
| 57 | MP0002254_reproductive_system_inflammat | 1.17279787 |
| 58 | MP0004484_altered_response_of | 1.14556066 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.11622207 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.11142925 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08295486 |
| 62 | MP0002108_abnormal_muscle_morphology | 1.08099477 |
| 63 | MP0005451_abnormal_body_composition | 1.07971679 |
| 64 | MP0005423_abnormal_somatic_nervous | 1.07344112 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05399429 |
| 66 | MP0003941_abnormal_skin_development | 1.00358812 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.97242695 |
| 68 | MP0003950_abnormal_plasma_membrane | 0.95859096 |
| 69 | MP0004233_abnormal_muscle_weight | 0.95398916 |
| 70 | MP0003279_aneurysm | 0.94656795 |
| 71 | MP0003879_abnormal_hair_cell | 0.94246880 |
| 72 | MP0004085_abnormal_heartbeat | 0.93308292 |
| 73 | MP0000579_abnormal_nail_morphology | 0.92693333 |
| 74 | MP0002060_abnormal_skin_morphology | 0.90971824 |
| 75 | MP0005266_abnormal_metabolism | 0.90487327 |
| 76 | MP0003186_abnormal_redox_activity | 0.87648922 |
| 77 | MP0008569_lethality_at_weaning | 0.85711849 |
| 78 | MP0009643_abnormal_urine_homeostasis | 0.84535784 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 0.84265724 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 0.82087633 |
| 81 | MP0005165_increased_susceptibility_to | 0.81558484 |
| 82 | MP0004859_abnormal_synaptic_plasticity | 0.81370539 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.80293367 |
| 84 | MP0009384_cardiac_valve_regurgitation | 0.79721758 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.79559620 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.78985824 |
| 87 | MP0003828_pulmonary_edema | 0.75454746 |
| 88 | MP0000733_abnormal_muscle_development | 0.72281121 |
| 89 | MP0005334_abnormal_fat_pad | 0.71791753 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.71760642 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.70803700 |
| 92 | MP0001661_extended_life_span | 0.70697571 |
| 93 | MP0003011_delayed_dark_adaptation | 0.70184886 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.69870412 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.69655693 |
| 96 | MP0003868_abnormal_feces_composition | 0.69337747 |
| 97 | MP0001958_emphysema | 0.67518961 |
| 98 | MP0000343_altered_response_to | 0.65050295 |
| 99 | MP0009697_abnormal_copulation | 0.62235810 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.61656839 |
| 101 | MP0005501_abnormal_skin_physiology | 0.61199210 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 0.59678150 |
| 103 | MP0001764_abnormal_homeostasis | 0.59379381 |
| 104 | MP0000598_abnormal_liver_morphology | 0.58174114 |
| 105 | MP0005376_homeostasis/metabolism_phenot | 0.58046956 |
| 106 | MP0005023_abnormal_wound_healing | 0.57220859 |
| 107 | MP0004272_abnormal_basement_membrane | 0.56339230 |
| 108 | MP0002128_abnormal_blood_circulation | 0.55842670 |
| 109 | MP0010234_abnormal_vibrissa_follicle | 0.55511141 |
| 110 | MP0005535_abnormal_body_temperature | 0.54511306 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.53803159 |
| 112 | MP0000427_abnormal_hair_cycle | 0.53603526 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.53561065 |
| 114 | MP0005647_abnormal_sex_gland | 0.53548504 |
| 115 | MP0000266_abnormal_heart_morphology | 0.53151830 |
| 116 | MP0003045_fibrosis | 0.52623194 |
| 117 | MP0009672_abnormal_birth_weight | 0.48829509 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.48314835 |
| 119 | MP0003690_abnormal_glial_cell | 0.47042381 |
| 120 | MP0005409_darkened_coat_color | 0.46510540 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.46314375 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.45249460 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.44049905 |
| 124 | MP0003329_amyloid_beta_deposits | 0.42819891 |
| 125 | MP0000462_abnormal_digestive_system | 0.42403037 |
| 126 | MP0003635_abnormal_synaptic_transmissio | 0.42052633 |
| 127 | MP0000467_abnormal_esophagus_morphology | 0.41824125 |
| 128 | MP0001502_abnormal_circadian_rhythm | 0.41697924 |
| 129 | MP0002064_seizures | 0.39306460 |
| 130 | MP0001440_abnormal_grooming_behavior | 0.38628891 |
| 131 | MP0001346_abnormal_lacrimal_gland | 0.38520313 |
| 132 | MP0008874_decreased_physiological_sensi | 0.36784524 |
| 133 | MP0009115_abnormal_fat_cell | 0.36733376 |
| 134 | MP0002066_abnormal_motor_capabilities/c | 0.36322956 |
| 135 | MP0001486_abnormal_startle_reflex | 0.35905466 |
| 136 | MP0004381_abnormal_hair_follicle | 0.35313752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.85036682 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.49888641 |
| 3 | Sudden death (HP:0001699) | 4.32891354 |
| 4 | Myoglobinuria (HP:0002913) | 4.29977100 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.19831824 |
| 6 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.19528158 |
| 7 | * Hyporeflexia of lower limbs (HP:0002600) | 4.17636204 |
| 8 | Muscle fiber splitting (HP:0003555) | 4.14391416 |
| 9 | Muscle fiber inclusion bodies (HP:0100299) | 4.09380522 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 4.09168784 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.08129167 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.05062753 |
| 13 | Xanthomatosis (HP:0000991) | 3.93423518 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.88038113 |
| 15 | Increased connective tissue (HP:0009025) | 3.84829093 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.83197661 |
| 17 | Ventricular tachycardia (HP:0004756) | 3.80295923 |
| 18 | * Distal lower limb muscle weakness (HP:0009053) | 3.69987822 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.69948926 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69016902 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 3.65878123 |
| 22 | Nemaline bodies (HP:0003798) | 3.60426001 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.57277183 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.48785893 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.40898302 |
| 26 | Hyperammonemia (HP:0001987) | 3.40561775 |
| 27 | Ketosis (HP:0001946) | 3.38971401 |
| 28 | Abnormality of the calf musculature (HP:0001430) | 3.38421049 |
| 29 | Distal arthrogryposis (HP:0005684) | 3.38089422 |
| 30 | Rimmed vacuoles (HP:0003805) | 3.34316931 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.33943827 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.28624189 |
| 33 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.22625381 |
| 34 | Difficulty running (HP:0009046) | 3.21526673 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.19601252 |
| 36 | Ketoacidosis (HP:0001993) | 3.17815506 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 3.08964295 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.08213450 |
| 39 | Complement deficiency (HP:0004431) | 3.04426756 |
| 40 | Distal lower limb amyotrophy (HP:0008944) | 3.02315471 |
| 41 | Calcaneovalgus deformity (HP:0001848) | 2.99231064 |
| 42 | Frequent falls (HP:0002359) | 2.95724630 |
| 43 | Hyperglycinuria (HP:0003108) | 2.94475441 |
| 44 | * EMG: neuropathic changes (HP:0003445) | 2.90775681 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 2.87904755 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.87182540 |
| 47 | Lipoatrophy (HP:0100578) | 2.86099339 |
| 48 | Palpitations (HP:0001962) | 2.85593936 |
| 49 | Myotonia (HP:0002486) | 2.84960506 |
| 50 | Round ear (HP:0100830) | 2.84324345 |
| 51 | Muscle stiffness (HP:0003552) | 2.81710238 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.77847203 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.75942327 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.75942327 |
| 55 | Scapular winging (HP:0003691) | 2.75247066 |
| 56 | Abnormality of the foot musculature (HP:0001436) | 2.74471371 |
| 57 | Hyperglycinemia (HP:0002154) | 2.69775153 |
| 58 | * Areflexia of lower limbs (HP:0002522) | 2.66836654 |
| 59 | Difficulty climbing stairs (HP:0003551) | 2.65512439 |
| 60 | Bulbar palsy (HP:0001283) | 2.62966524 |
| 61 | Atrial fibrillation (HP:0005110) | 2.62566616 |
| 62 | Foot dorsiflexor weakness (HP:0009027) | 2.62187864 |
| 63 | Generalized muscle weakness (HP:0003324) | 2.62028291 |
| 64 | Deformed tarsal bones (HP:0008119) | 2.61817639 |
| 65 | Epidermoid cyst (HP:0200040) | 2.61560894 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61460056 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.61460056 |
| 68 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.58769051 |
| 69 | Atrioventricular block (HP:0001678) | 2.55468792 |
| 70 | Dilated cardiomyopathy (HP:0001644) | 2.52139217 |
| 71 | Spinal rigidity (HP:0003306) | 2.47660010 |
| 72 | Gowers sign (HP:0003391) | 2.47525684 |
| 73 | Lower limb amyotrophy (HP:0007210) | 2.44283027 |
| 74 | Primary atrial arrhythmia (HP:0001692) | 2.43357044 |
| 75 | Cerebral edema (HP:0002181) | 2.42483014 |
| 76 | Cholelithiasis (HP:0001081) | 2.38451225 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 2.35966187 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.34702189 |
| 79 | Skin nodule (HP:0200036) | 2.32562944 |
| 80 | Supraventricular tachycardia (HP:0004755) | 2.31605962 |
| 81 | Heart block (HP:0012722) | 2.31510916 |
| 82 | Abnormality of the common coagulation pathway (HP:0010990) | 2.31117793 |
| 83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.31091370 |
| 84 | Fetal akinesia sequence (HP:0001989) | 2.30335501 |
| 85 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.30076321 |
| 86 | Subaortic stenosis (HP:0001682) | 2.30076321 |
| 87 | Myopathic facies (HP:0002058) | 2.29900531 |
| 88 | Supraventricular arrhythmia (HP:0005115) | 2.27837048 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.26691674 |
| 90 | Bundle branch block (HP:0011710) | 2.26191263 |
| 91 | Syncope (HP:0001279) | 2.26063956 |
| 92 | Ventricular arrhythmia (HP:0004308) | 2.25026660 |
| 93 | Abnormality of complement system (HP:0005339) | 2.24796779 |
| 94 | Absent phalangeal crease (HP:0006109) | 2.24638142 |
| 95 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20527945 |
| 96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20364000 |
| 97 | Abnormality of methionine metabolism (HP:0010901) | 2.20002961 |
| 98 | Weak cry (HP:0001612) | 2.18834176 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17721238 |
| 100 | Abnormal finger flexion creases (HP:0006143) | 2.17432470 |
| 101 | Metabolic acidosis (HP:0001942) | 2.13926447 |
| 102 | Hyperglycemia (HP:0003074) | 2.11405620 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 2.10970277 |
| 104 | Muscular dystrophy (HP:0003560) | 2.09722111 |
| 105 | Ulnar deviation of the wrist (HP:0003049) | 2.09204433 |
| 106 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.09091302 |
| 107 | Late onset (HP:0003584) | 2.07586969 |
| 108 | Ventricular fibrillation (HP:0001663) | 2.07132493 |
| 109 | Lethargy (HP:0001254) | 2.05023955 |
| 110 | Abnormality of the intrinsic pathway (HP:0010989) | 2.03697877 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 2.03341525 |
| 112 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.02150861 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 2.01667201 |
| 114 | Neck muscle weakness (HP:0000467) | 2.00768864 |
| 115 | Proximal amyotrophy (HP:0007126) | 1.98810991 |
| 116 | Facial diplegia (HP:0001349) | 1.98083314 |
| 117 | Malignant hyperthermia (HP:0002047) | 1.97532437 |
| 118 | Hip contracture (HP:0003273) | 1.97249816 |
| 119 | Conjunctival hamartoma (HP:0100780) | 1.96531282 |
| 120 | Progressive muscle weakness (HP:0003323) | 1.95893929 |
| 121 | Hepatic necrosis (HP:0002605) | 1.94622512 |
| 122 | Limb-girdle muscle atrophy (HP:0003797) | 1.92752628 |
| 123 | Fatigable weakness (HP:0003473) | 1.92498059 |
| 124 | Abnormality of the neuromuscular junction (HP:0003398) | 1.92498059 |
| 125 | Slender build (HP:0001533) | 1.92312839 |
| 126 | Neonatal onset (HP:0003623) | 1.91522032 |
| 127 | Hypercholesterolemia (HP:0003124) | 1.89401246 |
| 128 | Gout (HP:0001997) | 1.88534426 |
| 129 | Joint hemorrhage (HP:0005261) | 1.88041331 |
| 130 | Fat malabsorption (HP:0002630) | 1.87273533 |
| 131 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86939056 |
| 132 | Testicular atrophy (HP:0000029) | 1.86824122 |
| 133 | Waddling gait (HP:0002515) | 1.82047980 |
| 134 | Popliteal pterygium (HP:0009756) | 1.81242041 |
| 135 | Hyperkalemia (HP:0002153) | 1.79287041 |
| 136 | Steppage gait (HP:0003376) | 1.75687189 |
| 137 | Aplasia of the musculature (HP:0100854) | 1.71128256 |
| 138 | Prolonged QT interval (HP:0001657) | 1.70301709 |
| 139 | Palmoplantar keratoderma (HP:0000982) | 1.66903396 |
| 140 | Left ventricular hypertrophy (HP:0001712) | 1.61988929 |
| 141 | Abnormality of the calcaneus (HP:0008364) | 1.61372730 |
| 142 | Abnormal EKG (HP:0003115) | 1.60892421 |
| 143 | Generalized amyotrophy (HP:0003700) | 1.59251495 |
| 144 | Limb-girdle muscle weakness (HP:0003325) | 1.59055645 |
| 145 | Sudden cardiac death (HP:0001645) | 1.58085657 |
| 146 | Hypoplastic heart (HP:0001961) | 1.57474949 |
| 147 | Metatarsus adductus (HP:0001840) | 1.54473724 |
| 148 | Limited hip movement (HP:0008800) | 1.49740404 |
| 149 | Rapidly progressive (HP:0003678) | 1.43220753 |
| 150 | Easy fatigability (HP:0003388) | 1.42409850 |
| 151 | Diaphragmatic weakness (HP:0009113) | 1.40794617 |
| 152 | Infantile muscular hypotonia (HP:0008947) | 1.37774371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.58615291 |
| 2 | OBSCN | 4.11080154 |
| 3 | BCKDK | 3.99361186 |
| 4 | TRIB3 | 3.68902844 |
| 5 | PHKG2 | 3.15981193 |
| 6 | PHKG1 | 3.15981193 |
| 7 | LMTK2 | 2.54320308 |
| 8 | PDK4 | 2.50573616 |
| 9 | PDK3 | 2.50573616 |
| 10 | PKN2 | 2.37654758 |
| 11 | ERN1 | 2.36331163 |
| 12 | MAPKAPK3 | 2.14884138 |
| 13 | SIK1 | 2.14581364 |
| 14 | PIK3CG | 2.09807759 |
| 15 | MYLK | 2.03184500 |
| 16 | PINK1 | 1.98575167 |
| 17 | FGFR4 | 1.85829630 |
| 18 | NEK1 | 1.82768356 |
| 19 | MAP2K3 | 1.68098628 |
| 20 | MAP3K3 | 1.66444408 |
| 21 | MUSK | 1.64458420 |
| 22 | PDK2 | 1.59241421 |
| 23 | PIK3CA | 1.58683999 |
| 24 | LATS2 | 1.53140729 |
| 25 | EPHA2 | 1.53099894 |
| 26 | MARK1 | 1.48692795 |
| 27 | DMPK | 1.46106568 |
| 28 | NEK9 | 1.36140411 |
| 29 | MAP3K7 | 1.26306167 |
| 30 | INSRR | 1.25041522 |
| 31 | MAP2K4 | 1.20344774 |
| 32 | RIPK1 | 1.19748891 |
| 33 | LATS1 | 1.19276352 |
| 34 | MAPK12 | 1.09991856 |
| 35 | EPHA3 | 1.09395417 |
| 36 | FER | 1.08305200 |
| 37 | TESK1 | 1.08069321 |
| 38 | EPHB1 | 1.08017552 |
| 39 | MST1R | 1.07903249 |
| 40 | FLT3 | 1.06050789 |
| 41 | TIE1 | 1.05979636 |
| 42 | STK38L | 1.04509001 |
| 43 | CAMK2B | 1.03908506 |
| 44 | PAK3 | 1.00147377 |
| 45 | PDGFRA | 0.97253771 |
| 46 | PTK6 | 0.93126702 |
| 47 | STK24 | 0.90778687 |
| 48 | CAMK1 | 0.89237500 |
| 49 | EPHB2 | 0.88720467 |
| 50 | PRKD1 | 0.85735414 |
| 51 | PRKAA2 | 0.85462032 |
| 52 | EEF2K | 0.85040002 |
| 53 | TRPM7 | 0.82703808 |
| 54 | ROCK1 | 0.79722498 |
| 55 | PAK6 | 0.79659445 |
| 56 | MAP3K12 | 0.78868279 |
| 57 | ERBB4 | 0.78327732 |
| 58 | LIMK1 | 0.76962958 |
| 59 | CAMK4 | 0.76667791 |
| 60 | ILK | 0.76627939 |
| 61 | GRK7 | 0.75037253 |
| 62 | CAMK2G | 0.74755211 |
| 63 | ROCK2 | 0.74334394 |
| 64 | MAP3K11 | 0.74236342 |
| 65 | CAMK2A | 0.73448088 |
| 66 | PRKAA1 | 0.73397409 |
| 67 | MAPK11 | 0.72070833 |
| 68 | CAMK2D | 0.68967238 |
| 69 | MAP3K5 | 0.68645342 |
| 70 | NTRK1 | 0.65525768 |
| 71 | MAP2K6 | 0.64928202 |
| 72 | ICK | 0.64633025 |
| 73 | PKN1 | 0.64166699 |
| 74 | TGFBR2 | 0.63814276 |
| 75 | MET | 0.63281519 |
| 76 | SGK3 | 0.63090086 |
| 77 | NME1 | 0.61159771 |
| 78 | MAPK7 | 0.60394838 |
| 79 | MAP3K9 | 0.60136125 |
| 80 | RET | 0.60098341 |
| 81 | KDR | 0.59293236 |
| 82 | ARAF | 0.57735189 |
| 83 | LRRK2 | 0.56653230 |
| 84 | MAP3K1 | 0.54876485 |
| 85 | NEK6 | 0.54718234 |
| 86 | EPHA4 | 0.54291282 |
| 87 | MOS | 0.53340136 |
| 88 | PTK2 | 0.53315364 |
| 89 | PRPF4B | 0.51966252 |
| 90 | KSR2 | 0.50888408 |
| 91 | MAP3K6 | 0.49523792 |
| 92 | NTRK3 | 0.49240465 |
| 93 | PRKACG | 0.48533873 |
| 94 | PRKD3 | 0.48411985 |
| 95 | MAP3K2 | 0.46855420 |
| 96 | SGK2 | 0.46772157 |
| 97 | ABL2 | 0.44984112 |
| 98 | MTOR | 0.43593077 |
| 99 | DAPK2 | 0.42615188 |
| 100 | SCYL2 | 0.42552533 |
| 101 | PDPK1 | 0.42135614 |
| 102 | AKT2 | 0.42124064 |
| 103 | MARK2 | 0.41867350 |
| 104 | MAPK10 | 0.41197119 |
| 105 | FGFR3 | 0.41071169 |
| 106 | PRKG1 | 0.40755698 |
| 107 | UHMK1 | 0.40001331 |
| 108 | RPS6KA2 | 0.39473429 |
| 109 | MAPK4 | 0.39332490 |
| 110 | SGK223 | 0.38745858 |
| 111 | SGK494 | 0.38745858 |
| 112 | JAK2 | 0.38529082 |
| 113 | MAP3K13 | 0.38101572 |
| 114 | STK38 | 0.37037484 |
| 115 | TAOK1 | 0.36763301 |
| 116 | RPS6KC1 | 0.36739065 |
| 117 | RPS6KL1 | 0.36739065 |
| 118 | JAK1 | 0.36723747 |
| 119 | * MAP2K1 | 0.36505691 |
| 120 | DAPK3 | 0.36498716 |
| 121 | AKT3 | 0.36177287 |
| 122 | TAOK2 | 0.35881039 |
| 123 | FGFR2 | 0.33822614 |
| 124 | RPS6KA3 | 0.32308566 |
| 125 | PRKACB | 0.32172974 |
| 126 | RPS6KB2 | 0.32116583 |
| 127 | ZAK | 0.32062349 |
| 128 | CDC42BPA | 0.31998892 |
| 129 | ERBB3 | 0.31833215 |
| 130 | GRK5 | 0.30951041 |
| 131 | ERBB2 | 0.30940769 |
| 132 | DYRK1B | 0.30838296 |
| 133 | RPS6KA6 | 0.30450048 |
| 134 | DDR2 | 0.30049181 |
| 135 | GSK3A | 0.29942221 |
| 136 | PRKG2 | 0.29808820 |
| 137 | PAK2 | 0.29466298 |
| 138 | FRK | 0.29041140 |
| 139 | FGFR1 | 0.27405952 |
| 140 | * PRKACA | 0.27278299 |
| 141 | MAP2K2 | 0.27173009 |
| 142 | CAMK1D | 0.26338865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.79225684 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.25878379 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.12975913 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.91541137 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.83031802 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.82082118 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.80223880 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75038353 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68263342 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56503464 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.37743735 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.35881943 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.21518999 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09629082 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05955626 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05350122 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03501263 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89209706 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79687602 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79665795 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.76096128 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64542057 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61956677 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59720868 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54319770 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52112082 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.51316421 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49324236 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49177423 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48238539 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48032932 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47049487 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46484220 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46406822 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45399493 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44098868 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40907544 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38811239 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38650171 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38534446 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26025083 |
| 42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.23823782 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.22385687 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19594599 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.19524717 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.16142918 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.14104160 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 1.13609575 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10584361 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09046105 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06882803 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06137510 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 1.05173242 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01607857 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00630971 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98708363 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98611328 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97444116 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97165219 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95990236 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95095057 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94544412 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93221397 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92041426 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91120643 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.88546071 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84644447 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84390377 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82330741 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.81246944 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80733239 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79528680 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79141028 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77778119 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.77609699 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77173565 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76066352 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73977602 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72435388 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72301721 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71721103 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.70201426 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67348881 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67240344 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.66326340 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64250156 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64068274 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62563005 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61222031 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60290918 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.59151338 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58435025 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.57520389 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57394471 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56459648 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54832266 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54584315 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54296965 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53818864 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52971492 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.52435745 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52321405 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49100258 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48937526 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48273949 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47082416 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46563465 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46559000 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46338398 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46157719 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44976090 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44648132 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44377494 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44037718 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43538815 |
| 116 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42275296 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41564458 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39792701 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39142009 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37963915 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36945671 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36432895 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.35989882 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35702212 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35402547 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34929549 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34917044 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33161757 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32127574 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31809331 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.27437667 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26844591 |
| 133 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.26197083 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25056087 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22622289 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.20058018 |
| 137 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16732210 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.16543291 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16073799 |
| 140 | Viral myocarditis_Homo sapiens_hsa05416 | 0.15382851 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15265458 |
| 142 | Tight junction_Homo sapiens_hsa04530 | 0.12797795 |
| 143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07810771 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.04662911 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03405529 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.03248837 |
| 147 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02736624 |

